|
|
 |
|
Viewing report
|
|
|
|
High Growth Diagnostics: Technology and Market Analyses
Drug and Market Development Publishing, July 2006, Pages: 108
This report focuses on the market segments within the diagnostics industry that are currently experiencing robust growth. This report also analyzes the technologies, markets (both qualitatively and quantitatively), and key companies within this space.
Genomics advances of the 1990s are now resulting in commercial products-both analyte-specific reagents (ASRs) and in vitro diagnostics (IVDs).
Questions Answered in this report:
- Qualitative trends-market drivers, market challenges, bottlenecks, opportunities-in selected high-growth diagnostics segments.
- Quantitative Analysis of Market Segments that together contribute to the growth of the diagnostics space.
- Organisms of importance (have wide market appeal) for infectious disease (ID) diagnostics to be built around.
- Agents of Bio Defense relevance for which diagnostics must be developed-another segment of market opportunity.
Market Opportunities:
- Growth opportunity for tools developers to develop reagents, ASRs, technologies, hardware/instrumentation to address the diagnostics growth marketplace.
- Content companies can use this publication to ask where else they can invest.
- Diagnostics companies can use this publication to ask which diagnostics they can license-in, or in guidance to M&A transactions.
About the Author:
Dr. Enal Razvi is the author of this report and an expert on biotechnology business development and technology commercialization. Dr. Razvi has served as Vice President of Business Development at DiscoveRx Corporation in Fremont, California. Before DiscoveRx, at LJL BioSystems (Sunnyvale, CA), Dr. Razvi served as Senior Director of Business Development and played a major role in developing LJL BioSystems' SNP genotyping business. Subsequent to the acquisition of LJL BioSystems by Molecular Devices Corporation, Dr. Razvi ran Molecular Devices' Genomics business. Prior to LJL, while at Frost & Sullivan, Dr. Razvi served as Director of their Drug Discovery Consulting business. Dr. Razvi holds a doctorate in biomedical sciences from the University of Massachusetts Medical School, and completed post-doctoral work at The Rockefeller University in New York and at Harvard Medical School.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Molecular Diagnostics Markets
Molecular Diagnostics - Technologies, Markets and Companies
Molecular Diagnostics - Global Strategic Business Report
Companion Diagnostics in Personalized Medicine and Cancer Therapy
Molecular Diagnostics: A Primer on an Emerging Sector
The Japanese Cancer Diagnostics Market
The UK Cancer Diagnostics Market
The US Cancer Diagnostics Market
The French Cancer Diagnostics Market
The German Cancer Diagnostics Market
The Italian Cancer Diagnostics Market
Molecular Diagnostics - A World Market Review
|
|
|
|
